Chemical Compound

Insulinotropin

CAS Registry Number 107444-51-9
Back to search Request a Quote
Insulinotropin chemical structure
Primary Record

Insulinotropin

In stock
622 g
Purity
98.1 %
CAS
107444-51-9

Compound Identifiers & Properties

CAS
107444-51-9
PubChem CID
16133831
SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CNC=N6)N
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C

Names & Synonyms

  • Insulinotropin
  • 107444-51-9
  • Insulinotropin (human)
  • GLP-1
  • Glucagon-like peptide 1
  • Glucagon-like peptide-1
  • Proglucagon (78-107)
  • Glucagon Like Peptide 1
  • RefChem:922267
  • Rat GLP-I(7-36)amide
  • UNII-0JS9125PIZ
  • GLP-1(7-36) amide
  • Glucagon-like peptide-I(7-36) amide
  • GLP-1 (7-36) amide
  • GLP-1(7-36), amide
  • Preproglucagon 78-107 Amide
  • GLP 1
  • Glp-I (7-36)
  • Human GLP-1-(7-36)-amide
  • GLP-1(7-36)amide[rat]
  • MKC 253
  • GLP-1(7-36)
  • 0JS9125PIZ
  • Glucagon-like Peptide 1 (7-36) amide
  • Glucagon-like peptide I (7-36)
  • Glucagon-like peptide 1 (7-36)
  • GLP-17-3
  • SCHEMBL29353318
  • GLP-1 (7-36) amide Acetate
  • Glucagon-like peptide 1(7-36)
  • BDBM741295
  • DTXCID901772398
  • DTXSID001365300
  • DTXSID701343589
  • GLXC-21149
  • Human GLP-1 (7-36)-NH2
  • EX-A14224
  • GLP-1 [7-36]
  • AKOS024456935
  • ACN-057299
  • BAT-006200
  • BAT-010849
  • C149H226N40O45
  • 107444-51-9 (net)
  • Glucagon-like Peptide-1 (7-36) Amide
  • US20250161476, Compound GLP1
  • DA-53583
  • GLP-1-(7-36)
  • Human glucagon-like peptide-1-(7-36) amide
  • TS-08934
  • GLP-1 (7-36) amide trifluoroacetate salt
  • Glucagon-like peptide 1 (7-36) amide (human, rat)
  • GLUCAGON-LIKE PEPTIDE I FRAGMENT 7-36 AMIDE HUMAN
  • J924.573A
  • C149-H226-N40-O45
  • A16895
  • A946982
  • Glucagon-like peptide i fragment 7-36*amide human
  • Glucagon-Like Peptide I Amide Fragment 7-36 human
  • (4S)-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[2-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-2-oxoethyl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-methyl-1-oxobuta
  • N0001-013062
  • GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) trifluoroacetate salt
  • 89750-14-1
  • Glucagon-Like Peptide I Amide Fragment 7-36 human, >=97% (HPLC), powder
  • Glucagon-Like Peptide 1 (7-36) amide (human, bovine, guinea pig, mouse, rat)
  • (4S)-4-[({[(1S,2R)-1-{[(1S)-1-{[(1S,2R)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-[({[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-[({[(1S)-4-CARBAMIMIDAMIDO-1-CARBAMOYLBUTYL]CARBAMOYL}METHYL)CARBAMOYL]PENTYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-(1H-INDOL-3-YL)ETHYL]CARBAMOYL}ETHYL]CARBAMOYL}-2-METHYLBUTYL]CARBAMOYL}-2-PHENYLETHYL]CARBAMOYL}-3-CARBOXYPROPYL]CARBAMOYL}PENTYL]CARBAMOYL}ETHYL]CARBAMOYL}ETHYL]CARBAMOYL}-3-CARBAMOYLPROPYL]CARBAMOYL}METHYL)CARBAMOYL]-3-CARBOXYPROPYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}-2-CARBOXYETHYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}-2-HYDROXYPROPYL]CARBAMOYL}-2-PHENYLETHYL]CARBAMOYL}-2-HYDROXYPROPYL]CARBAMOYL
  • Glucagon-related peptide 1 (Rana catesbeiana), 3-L-glutamic acid-10-L-valine-16-glycine-17-L-glutamine-23-L-isoleucine-24-L-alanine-27-L-valine-30-L-argininamide-31-de-L-proline-32-de-L-lysine-
  • L-Argininamide, L-histidyl-L-alanyl-L-I+/--glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-I+/--aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-I+/--glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-I+/--glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-lysylglycyl-